Moxifloxacin

Product manufactured by Apotex Corp.

Application Nr Approved Date Route Status External Links
ANDA090080 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Moxifloxacin Ophthalmic Solution Is Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Strains Of The Following Organisms: Corynebacterium Species* Micrococcus Luteus* Staphylococcus Aureus Staphylococcus Epidermidis Staphylococcus Haemolyticus Staphylococcus Hominis Staphylococcus Warneri* Streptococcus Pneumoniae Streptococcus Viridans Group Acinetobacter Lwoffii* Haemophilus Influenza Haemophilus Parainfluenzae* Chlamydia Trachomatis *efficacy For This Organism Was Studied In Fewer Than 10 Infections. Moxifloxacin Ophthalmic Solution Is A Topical Fluoroquinolone Anti-Infective Indicated For The Treatment Of Bacterial Conjunctivitis Caused By Susceptible Strains Of The Following Organisms: Corynebacterium Species* , Micrococcus Luteus*, Staphylococcus Aureus, Staphylococcus Epidermidis, Staphylococcus Haemolyticus, Staphylococcus Hominis, Staphylococcus Warneri*, Streptococcus Pneumoniae, Streptococcus Viridans Group , Acinetobacter Lwoffii*, Haemophilus Influenzae, Haemophilus Parainfluenzae*, Chlamydia Trachomatis *efficacy For This Organism Was Studied In Fewer Than 10 Infections. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Moxifloxacin Hydrochloride Monohydrate

Comments